Total Payments
$6,042
2024 Payments
$1,350
Companies
43
Transactions
339
Medicare Patients
4,530
Medicare Billing
$313,170
Payment Breakdown by Category
Food & Beverage$5,938 (98.3%)
Education$103.89 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,938 | 337 | 98.3% |
| Education | $103.89 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,061 | 71 | $0 (2024) |
| Lilly USA, LLC | $558.02 | 37 | $0 (2024) |
| Novo Nordisk Inc | $483.40 | 33 | $0 (2024) |
| PFIZER INC. | $357.21 | 22 | $0 (2024) |
| Amgen Inc. | $344.27 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $299.42 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $282.35 | 12 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $277.36 | 15 | $0 (2024) |
| Astellas Pharma US Inc | $184.13 | 7 | $0 (2024) |
| Abbott Laboratories | $165.27 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,350 | 73 | ABBVIE INC. ($340.56) |
| 2023 | $2,048 | 98 | ABBVIE INC. ($369.11) |
| 2022 | $1,352 | 74 | Lilly USA, LLC ($191.38) |
| 2021 | $1,292 | 94 | AbbVie Inc. ($223.46) |
All Payment Transactions
339 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: VACCINE | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.48 | General |
| 10/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Biological | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: PAIN | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: DIABETES | ||||||
| 09/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Diabetes Care | ||||||
| 09/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.59 | General |
| 08/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Inflammation | ||||||
| 08/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,029 | 2,196 | $137,030 | $74,537 |
| 2022 | 18 | 1,250 | 2,523 | $154,008 | $82,139 |
| 2021 | 17 | 1,149 | 2,341 | $146,995 | $84,173 |
| 2020 | 16 | 1,102 | 2,206 | $142,115 | $72,321 |
Total Patients
4,530
Total Services
9,266
Medicare Billing
$313,170
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 253 | 646 | $83,680 | $46,847 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 294 | $28,370 | $14,758 | 52.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 211 | 468 | $4,680 | $3,931 | 84.0% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 16 | 16 | $2,800 | $2,236 | 79.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 48 | 50 | $3,000 | $1,731 | 57.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 33 | 66 | $2,310 | $1,071 | 46.3% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 31 | 31 | $1,550 | $983.32 | 63.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $960.00 | $925.76 | 96.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 28 | $1,840 | $846.55 | 46.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 54 | 71 | $2,130 | $581.12 | 27.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 60 | 84 | $1,680 | $330.96 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 30 | $1,610 | $250.29 | 15.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 37 | 328 | $1,640 | $28.17 | 1.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 13 | 52 | $780.00 | $17.48 | 2.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 251 | 574 | $71,750 | $39,882 | 55.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 249 | 498 | $44,820 | $24,740 | 55.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $6,345 | $5,001 | 78.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 73 | 82 | $4,920 | $2,862 | 58.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 51 | 61 | $3,660 | $1,841 | 50.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 227 | 486 | $4,860 | $1,440 | 29.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 31 | 68 | $2,380 | $1,111 | 46.7% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 35 | 35 | $1,340 | $1,047 | 78.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 36 | 36 | $900.00 | $882.50 | 98.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 30 | 30 | $750.00 | $739.00 | 98.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 52 | 77 | $2,310 | $666.07 | 28.8% |
About Torill Nelson
Torill Nelson is a Ambulatory Care healthcare provider based in Camden, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720032485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Torill Nelson has received a total of $6,042 in payments from pharmaceutical and medical device companies, with $1,350 received in 2024. These payments were reported across 339 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($5,938).
As a Medicare-enrolled provider, Nelson has provided services to 4,530 Medicare beneficiaries, totaling 9,266 services with total Medicare billing of $313,170. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Ambulatory Care
- Other Specialties Family
- Location Camden, SC
- Active Since 05/19/2006
- Last Updated 11/26/2012
- Taxonomy Code 163WP2201X
- Entity Type Individual
- NPI Number 1720032485
Products in Payments
- VRAYLAR (Drug) $454.04
- QULIPTA (Drug) $286.87
- TRINTELLIX (Drug) $255.49
- TRELEGY ELLIPTA (Drug) $253.73
- NURTEC ODT (Drug) $239.40
- UBRELVY (Drug) $215.03
- MOUNJARO (Drug) $201.59
- Otezla (Drug) $189.14
- JARDIANCE (Drug) $170.15
- TRULICITY (Drug) $164.18
- EMGALITY (Drug) $146.32
- QUVIVIQ (Drug) $137.93
- Barostim Neo System (Device) $136.12
- Omnipod (Device) $135.26
- XIFAXAN (Drug) $130.87
- AJOVY (Biological) $126.69
- Aimovig (Biological) $112.75
- Ozempic (Drug) $111.16
- SOLIQUA 100/33 (Biological) $102.08
- FARXIGA (Drug) $98.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.